0.58 USD
↘ 0.09 (13.40%)AT CLOSE (11:59 AM EDT)
Cue Biopharma, Inc.
CUENASDAQ • USD
0.59
↗ 0.01 (1.02%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.59
↗ 0.01 (1.02%)
Market: CLOSED
Open?$0.51
High?$0.63
Low?$0.49
Prev. Close?$0.67
Volume?10.3M
Avg. Volume?18.3M
VWAP?$0.55
Rel. Volume?0.56x
Bid / Ask
Bid?$0.49 × 100
Ask?$0.69 × 100
Spread?$0.20
Midpoint?$0.59
Valuation & Ratios
Market Cap?65.4M
Shares Out?97.3M
Float?94.7M
Float %?97.2%
P/E Ratio?N/A
P/B Ratio?2.48
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.74Strong
Quick Ratio?2.74Strong
Cash Ratio?2.01Strong
Debt/Equity?0.03Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.48CHEAP▾
P/S?2.38CHEAP▾
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
EV/Sales?1.42CHEAP▾
Returns & Efficiency
ROE?-100.6%WEAK▾
ROA?-63.0%WEAK▾
Cash Flow & Enterprise
FCF?$-21864000
Enterprise Value?$39.0M
News
Profile
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
Employees
29
Market Cap
65.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-01-02
Address
40 GUEST STREET
BOSTON, MA 02135
Phone: 617-949-2680
BOSTON, MA 02135
Phone: 617-949-2680